XML 109 R40.htm IDEA: XBRL DOCUMENT
v3.25.4

SHAREHOLDERS' EQUITY (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Stockholders' Equity Note [Abstract] |
Schedule of ordinary shares reserved for future issuance |
|  | As of December 31, |
|  | 2025 |  |  | 2024 |
Ordinary shares |  |  | 51,160,822 |  |  |  | 50,773,337 |
Outstanding share options and RSUs |  |  | 2,653,964 |  |  |  | 3,164,395 |
Shares available for future grants under the 2021 plan |  |  | 10,841,262 |  |  |  | 8,941,243 |
Shares available for future grants under the 2024 Foundation plan |  |  | 14,498 |  |  |  | 15,000 |
Shares subject to the employee share purchase plan |  |  | 1,048,635 |  |  |  | 1,156,437 |
Total |  |  | 65,719,181 |  |  |  | 64,050,412 |
Schedule of share option activity |
|  | Number of Options |  |  |  | Weighted- Average Exercise Price |  |  | Weighted Average Remaining Contractual life |  |  |  | Aggregate Intrinsic Value |
Outstanding — January 1, 2025 (*) |  |  | 1,768,230 |  |  | $ | 62.90 |  |  |  | 6.04 |  |  | $ | 305,379 |
Granted (*) |  |  | 42,897 |  |  | $ | 0.87 |  |  |  |  |  |  |  |  |
Exercised |  |  | (505,473) |  |  | $ | 37.85 |  |  |  |  |  |  |  |  |
Expired and forfeited |  |  | (48,587) |  |  | $ | 68.50 |  |  |  |  |  |  |  |  |
Outstanding — December 31, 2025 |  |  | 1,257,067 |  |  | $ | 70.64 |  |  |  | 5.17 |  |  | $ | 111,600 |
Exercisable — December 31, 2025(*) |  |  | 1,108,563 |  |  | $ | 71.39 |  |  |  | 4.93 |  |  | $ | 98,545 |
(*) Includes 73,074 performance-based options granted to the Company’s Co-CEOs in 2022, 74,108 in 2023, 22,481 in 2024 and 20,217 in 2025, as applicable.
Schedule of unvested restricted stock units |
|  |  | Number of Units |  |  |  | Weighted-Average Fair Value |
Balance at January 1, 2025 |  |  |  | 1,396,165 |  |  | $ | 177.72 |
Granted (*) |  |  |  | 871,602 |  |  | $ | 258.17 |
Vested |  |  |  | (658,123 | ) |  | $ | 185.31 |
Canceled |  |  |  | (212,747 | ) |  | $ | 195.19 |
Balance at December 31, 2025 (*) |  |  |  | 1,396,897 |  |  | $ | 221.68 |
Schedule of share-based compensation expense |
|  |  | Year ended December 31, |
|  |  | 2025 |  |  |  | 2024 |  |  |  | 2023 |
Cost of revenues |  | $ | 8,561 |  |  | $ | 6,603 |  |  | $ | 6,307 |
Research and development |  |  | 82,250 |  |  |  | 50,995 |  |  |  | 38,737 |
Sales and marketing |  |  | 44,084 |  |  |  | 33,865 |  |  |  | 25,395 |
General and administrative |  |  | 42,116 |  |  |  | 55,654 |  |  |  | 29,747 |
Share-based compensation, net of amounts capitalized |  | $ | 177,011 |  |  | $ | 147,117 |  |  | $ | 100,186 |
Capitalized share-based compensation costs |  |  | 1,814 |  |  |  | 1,144 |  |  |  | 1,997 |
Total share-based compensation |  | $ | 178,825 |  |  | $ | 148,261 |  |  | $ | 102,183 |

X
- Definition Schedule of aggregate number of common stock ordinary shares reserved for future issuance. + References No definition available. + Details
Name: | mndy_ScheduleOfCommonStockOrdinarySharesReservedForFutureIssuanceTableTextBlock
Namespace Prefix: | mndy_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in restricted stock units (RSUs). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration